Hanall Biopharma, Stock Price 23,350 KRW (-3.31%)... Bulletin Board 'Bustling'
At this time, posts about HanAll Biopharma are rapidly increasing on portals and securities communities. Today, foreign investors have net sold 12,601 shares of HanAll Biopharma, and institutions have net sold 72,000 shares, according to provisional data. HanAll Biopharma is known as an R&D-focused pharmaceutical and bio company.
As of 1:30 PM on the 17th, HanAll Biopharma's stock price is 23,350 KRW, down 3.31% from the previous day, with a trading volume of 862,180 shares, which is 86.11% of the 5-day average trading volume.
In addition to HanAll Biopharma, posts by investors are also rapidly increasing for POSCO International (047050), Ewha Electric (024810), and Dentis (261200).
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Living the Homebody Dream? "I Was Shocked by My Spending" How to Cut Costs to 5,000 Won for Essentials [The Principles of Benefits]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
※Source: AI Investment Assistant AI Rassi
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
